杏芎氯化钠注射液治疗急性脑梗塞32例临床观察

《杏芎氯化钠注射液治疗急性脑梗塞32例临床观察》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。

1、杏芎氯化钠注射液治疗急性脑梗塞32例临床观察【摘要】目的观察杏芎氯化钠注射液治疗急性脑梗塞的临床疗效。方法将62例急性脑梗塞患者随机分成治疗组和对照组。两组常规治疗方法相同。治疗组给予杏芎氯化钠注射液1次/d，静脉滴注；对照组加丹奥注射液、克林澳注射液2次/d，静脉滴注，脑细胞活化剂特安欣(肌氨肽苷)注射液1次/d，静脉滴注，2周后观察疗效。结果治疗组与对照组的总有效率分别为84.38%和86.66%(P>0.05),显效率分别为31.25%、36.67%(P>0.05)，均无显著性差异。治疗组在改善神经功能缺损方面明显好于对照组(P<0.

2、05)。结论杏芎氯化钠注射液治疗急性脑梗塞具有多种治疗作用，用药简便、疗效确切，而且在改善神经功能缺损方面作用较好，值得临床推广应用。【关键词】杏芎氯化钠注射液；急性脑梗塞；临床疗效　　Abstract:ObjectiveToobservethetherapeuticeffectofFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjectiononacutecerebralinfarction.MethodsSixtyt,treatmentgroup(32cases)andcontrolgr

3、oup(30cases).Bothofthegroupseordinarymethod.ThecasesofthetreatmentgroupGinkgoextractandTertramEthypyrazinesodiumchlorideinjectionqd,ivgtt.ThecasesofthecontrolgroupOzagrel,CinepazideMaleateinjection,bid,ivgtt.andMuscularAminoAcidsandPeptidesandNucleosidesInjectiontoobservetheefficac

4、y.ThetreatmentcourseentgroupandthecontrolgroupentgroupGinkgoextractandTertramEthypyrazinesodiumchlorideinjectioniseasilyusedandhasacocktailpositiveeffectonmanykindsoftreatmentactionandimprovementofneurologicalfunctiondefectinclinic,itisGinkgoextractandTertramEthypyrazinesodiumchlor

5、ideinjection,Acutecerebralinfarction,Curativeeffect　　Cerebralinfarctionisalsocalledischemiabrainstroke,amonandfrequentcerebrovasculardiseaseinclinic,itisthethirdleadingcauseofdeathinallkindsofdiseaseinmiddle-agedpopulationinclinicorbiditymortalityanddisability.Inrecentyearsacutecer

6、ebralinfarctionisincreasingtendtoyoung［1］，atpresentnosingleGinkgoextractandTertramEthypyrazinesodiumchlorideinjectioncandoit.Itoleculesethodtocureacutecerebralinfarction,butthedrughasn'tbeenusedforalongperiodoftime,lyintotreatmentgroup(32cases)andcontrolgroup(30cases)from62consecut

7、iveacutecerebralinfarctionpatientsadmittedtoourhospital.Diagnosisofacutecerebralinfarctionforeachcaseadeaccordingtostandardofcerebralinfarctiondiagnosisandbrainputedtomography(CT)and/ormagicresonanceimages(MRI)thediagnosis.Patientsorrhage,liverdisfunction,renaldisfunction,cardiovas

8、culardiseasesandhematologi